December 9, 2015

Cerberus Capital Management Invests $105M in PaxVax

Source: FiercePharma
Publication Date: December 9, 2015
Visit Source

A new $105 million investment by Cerberus Capital Management helps PaxVax focus on growing its typhoid vaccine business and launching its oral cholera vaccine.